These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 15915345)

  • 41. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients.
    Canonica GW; Passalacqua G
    Allergy; 2006; 61 Suppl 81():20-3. PubMed ID: 16792602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Apropos of sublingual specific immunotherapy].
    Sabbah A
    Allerg Immunol (Paris); 1998 Apr; 30(4):97-8. PubMed ID: 9631689
    [No Abstract]   [Full Text] [Related]  

  • 43. Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results.
    Esch RE; Bush RK; Peden D; Lockey RF
    Ann Allergy Asthma Immunol; 2008 May; 100(5):475-81. PubMed ID: 18517081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?
    Nelson HS
    J Allergy Clin Immunol Pract; 2014; 2(2):144-9; quiz 150-1. PubMed ID: 24607040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allergic rhinitis and its impact on asthma update: allergen immunotherapy.
    Passalacqua G; Durham SR;
    J Allergy Clin Immunol; 2007 Apr; 119(4):881-91. PubMed ID: 17418661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sublingual immunotherapy.
    Esch RE
    Curr Opin Otolaryngol Head Neck Surg; 2008 Jun; 16(3):260-4. PubMed ID: 18475082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient initiation and persistence with allergen immunotherapy.
    Anolik R; Schwartz AM; Sajjan S; Allen-Ramey F
    Ann Allergy Asthma Immunol; 2014 Jul; 113(1):101-7. PubMed ID: 24814759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Allergen-specific immunotherapy in the treatment of pollen allergy].
    Mailhol C; Didier A
    Rev Mal Respir; 2013 Feb; 30(2):142-51. PubMed ID: 23419445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allergen immunotherapy for long-term tolerance and prevention.
    Penagos M; Durham SR
    J Allergy Clin Immunol; 2022 Mar; 149(3):802-811. PubMed ID: 35085663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific immunotherapy in pollen allergy.
    Wallner M; Briza P; Thalhamer J; Ferreira F
    Curr Opin Mol Ther; 2007 Apr; 9(2):160-7. PubMed ID: 17458170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monoid sublingual immunotherapy.
    Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML
    Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunotherapy--traditional.
    Koshkareva YA; Krouse JH
    Otolaryngol Clin North Am; 2011 Jun; 44(3):741-52, x. PubMed ID: 21621058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Allergen-specific immunotherapy in allergic rhinitis].
    Klimek L; Grevers G
    MMW Fortschr Med; 2008 Feb; 150(9):29-33; quiz 34. PubMed ID: 18402267
    [No Abstract]   [Full Text] [Related]  

  • 55. Future forms of immunotherapy.
    Casale TB; Stokes JR
    J Allergy Clin Immunol; 2011 Jan; 127(1):8-15; quiz 16-7. PubMed ID: 21094518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Certainties and doubts about sublingual and oral immunotherapy in children.
    Larenas-Linnemann D
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):558-67. PubMed ID: 19812482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Role of allergen-specific immunotherapy (desensitization) for the treatment of allergies in Germany. Current situation].
    Kleine-Tebbe J; Ackermann-Simon J; Hanf G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Mar; 55(3):343-50. PubMed ID: 22373847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Meta-analyses of specific immunotherapy trials.
    Calderon MA
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():31-4. PubMed ID: 19221615
    [No Abstract]   [Full Text] [Related]  

  • 59. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sublingual immunotherapy for allergic rhinitis: an update.
    Passalacqua G; Compalati E; Canonica GW
    Curr Opin Otolaryngol Head Neck Surg; 2011 Feb; 19(1):43-7. PubMed ID: 21102336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.